News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
17 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (25218)
Month
January (2946)
February (2976)
March (2714)
April (2913)
May (3635)
June (2415)
July (2091)
August (2652)
September (2458)
October (418)
Day
1 (150)
2 (126)
3 (96)
5 (29)
6 (17)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
Day
1
2
3
5
6
Opinion
Gene Therapy’s Future Hinges on the Economics of Safety
Smarter design through targeted delivery and human-relevant testing can save the industry from costly safety failures.
October 6, 2025
·
7 min read
·
Ronald A. Li
Multiple sclerosis
Beyond BTK Inhibitors: Next Gen MS Treatments Could Transcend Symptom Management
While Bruton’s tyrosine kinase inhibitors are often hailed as the next big breakthrough in multiple sclerosis, Immunic Therapeutics and others are leveraging neuroprotective targets and remyelination to keep the disease at bay.
October 6, 2025
·
5 min read
·
Ben Hargreaves
Cell and Gene Therapy
Meeting on the Mesa Arrives Amid Mixed Signals for Cell and Gene Therapy
As industry leaders gather at the annual event in Phoenix, the cell and gene therapy space remains in a state of flux, with M&A activity and regulatory support signaling momentum while commercialization challenges continue to hinder broader investor interest.
October 6, 2025
·
5 min read
·
Ben Hargreaves
Press Releases
Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2025 World Muscle Society Congress
October 6, 2025
·
16 min read
Press Releases
Ensoma to Present New Preclinical Data at the Society for Immunotherapy of Cancer Annual Meeting
October 6, 2025
·
1 min read
Press Releases
FDA Grants RMAT Designation to Avobis Bio’s Implantable Cell Therapy AVB-114 for Crohn’s Perianal Fistulas
October 6, 2025
·
3 min read
Press Releases
MESA LABS DECLARES QUARTERLY DIVIDEND
October 6, 2025
·
2 min read
Press Releases
Solarea Bio Appoints New Chief Executive Officer
October 6, 2025
·
2 min read
Press Releases
Alto Neuroscience Receives FDA Fast Track Designation for ALTO-101 for the Treatment of Cognitive Impairment Associated with Schizophrenia
October 6, 2025
·
5 min read
Press Releases
Ironfist Therapeutics Announces Preclinical Proof of Concept for Novel Nanomedicine Radiopharmaceutical, Tamrada™
October 6, 2025
·
3 min read
1 of 2
Next
